Ausdal Financial Partners Inc. Decreases Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Ausdal Financial Partners Inc. lessened its position in shares of UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 9.8% in the third quarter, Holdings Channel reports. The fund owned 1,699 shares of the healthcare conglomerate’s stock after selling 184 shares during the quarter. Ausdal Financial Partners Inc.’s holdings in UnitedHealth Group were worth $857,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also bought and sold shares of the company. State Street Corp raised its stake in UnitedHealth Group by 1.7% during the 2nd quarter. State Street Corp now owns 46,313,751 shares of the healthcare conglomerate’s stock worth $22,260,241,000 after acquiring an additional 764,872 shares during the period. Geode Capital Management LLC boosted its holdings in UnitedHealth Group by 2.6% in the 2nd quarter. Geode Capital Management LLC now owns 17,546,024 shares of the healthcare conglomerate’s stock worth $8,410,038,000 after buying an additional 444,629 shares during the period. Morgan Stanley lifted its position in shares of UnitedHealth Group by 13.8% in the fourth quarter. Morgan Stanley now owns 15,635,038 shares of the healthcare conglomerate’s stock valued at $8,289,386,000 after acquiring an additional 1,893,192 shares in the last quarter. Moneta Group Investment Advisors LLC raised its stake in UnitedHealth Group by 100,076.4% during the 4th quarter. Moneta Group Investment Advisors LLC now owns 11,823,820 shares of the healthcare conglomerate’s stock valued at $6,268,753,000 after purchasing an additional 11,812,017 shares during the period. Finally, Alliancebernstein L.P. grew its holdings in UnitedHealth Group by 3.5% during the 2nd quarter. Alliancebernstein L.P. now owns 11,749,819 shares of the healthcare conglomerate’s stock valued at $5,647,433,000 after buying an additional 399,739 shares in the last quarter. 85.69% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

UNH has been the subject of several research reports. Stephens dropped their price objective on shares of UnitedHealth Group from $615.00 to $605.00 and set an “overweight” rating for the company in a report on Tuesday, January 16th. Oppenheimer reaffirmed an “outperform” rating and set a $610.00 price objective on shares of UnitedHealth Group in a report on Wednesday, January 17th. Cantor Fitzgerald restated an “overweight” rating and issued a $591.00 price target on shares of UnitedHealth Group in a research report on Friday, January 19th. Royal Bank of Canada restated an “outperform” rating and set a $596.00 target price on shares of UnitedHealth Group in a research report on Tuesday, January 16th. Finally, UBS Group upgraded UnitedHealth Group from a “neutral” rating to a “buy” rating and upped their price objective for the company from $520.00 to $640.00 in a research report on Monday, October 16th. One investment analyst has rated the stock with a sell rating, one has given a hold rating, thirteen have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $575.79.

Check Out Our Latest Research Report on UNH

UnitedHealth Group Stock Up 0.3 %

Shares of UNH traded up $1.56 during midday trading on Thursday, reaching $520.95. 1,210,602 shares of the stock were exchanged, compared to its average volume of 4,322,628. UnitedHealth Group Incorporated has a 52 week low of $445.68 and a 52 week high of $554.70. The company’s 50 day moving average is $526.60 and its two-hundred day moving average is $517.64. The company has a market capitalization of $481.84 billion, a P/E ratio of 21.79, a PEG ratio of 1.39 and a beta of 0.54. The company has a current ratio of 0.79, a quick ratio of 0.80 and a debt-to-equity ratio of 0.62.

UnitedHealth Group (NYSE:UNHGet Free Report) last issued its quarterly earnings data on Friday, January 12th. The healthcare conglomerate reported $6.16 EPS for the quarter, topping analysts’ consensus estimates of $5.98 by $0.18. The company had revenue of $94.43 billion during the quarter, compared to the consensus estimate of $92.13 billion. UnitedHealth Group had a net margin of 6.02% and a return on equity of 26.39%. UnitedHealth Group’s revenue for the quarter was up 14.1% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $5.34 earnings per share. On average, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 27.84 earnings per share for the current year.

Insider Buying and Selling at UnitedHealth Group

In other news, Director Stephen J. Hemsley sold 66,081 shares of the company’s stock in a transaction on Tuesday, December 5th. The stock was sold at an average price of $550.39, for a total transaction of $36,370,321.59. Following the transaction, the director now directly owns 635,528 shares of the company’s stock, valued at $349,788,255.92. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Insiders own 0.35% of the company’s stock.

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Further Reading

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.